Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma

American Journal of Surgical Pathology

Volumn 32, Issue 11, 2008, Pages 1675-1682

  Iguchi, Tomohiro ^a   Aishima, Shinichi ^a,b   Taketomi, Akinobu ^a   Nishihara, Yunosuke ^a   Fujita, Nobuhiro ^a   Sanefuji, Kensaku ^a   Maehara, Yoshihiko ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HAMANOMACHI HOSPITAL   (Japan)

Author keywords

Fc inf; Fibrous capsule; Hepatic resection; Infiltration; Liver

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TREATMENT OUTCOME; CANCER INVASION; CLASSIFICATION; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 56149107782     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31817a8ed5     Document Type: Article

References (30)

1. Arii S, Tanaka J, Yamazoe Y, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer. 1992;69:913-919.
2. Arii S, Mise M, Harada T, et al. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology. 1996;24:316-322.
3. Bedossa P, Peltier E, Terris B, et al. Transforming growth factorbeta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology. 1995;21:760-766.
4. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271-285.
5. Carcangiu ML, Bianchi S, Savino D, et al. Follicular Hurthle cell tumors of the thyroid gland. Cancer. 1991;68:1944-1953.
6. DeLellis RA, Lloyd RV, Heitz PU, et al. World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press; 2000:67-72.
7. Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg. 2003; 237:536-543.
8. Fletcher CDM. Diagnostic Histopathology of Tumors. Vol. 2. NY: Churchill Livingstone; 1995:979-993.
9. Grigioni WF, D'Errico A, Biagini G, et al. The capsule surrounding primary liver tumors: where from its prognostic significance? Int J Cancer. 1990;45:637-643.
10. Ishizaki M, Ashida K, Higashi T, et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch. 2001;438:574-580.
11. Jwo SC, Chiu JH, Chau GY, et al. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology. 1992;16:1367-1371.
12. Lai EC, Ng IO, Ng MM, et al. Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology. 1990;11:815-818.
13. Liotta LA. Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 1986;46:1-7.
14. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. Tokyo: Kanehara; 2000:13-32.
15. Liver (including intrahepatic bile ducts). Greene FL, Page DL, Fleming DL, et al, eds. In: American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002:131-138.
16. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-1917.
17. Nagao T, Goto S, Kawano N, et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg. 1987;205:33-40.
18. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105: 488-494.
19. Ng IO, Lai EC, Ng MM, et al. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer. 1992;70:45-49.
20. Okuda K, Musha H, Nakajima Y, et al. Clinicopathologic features of encapsulated hepatocellular carcinoma. A study of 26 cases. Cancer. 1977;40:1240-1245.
21. Ooi LP, Crawford DH, Gotley DC, et al. Evidence that "myofibroblast- like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol. 1997;26: 798-807.
22. Shimada M, Rikimaru T, Hamatsu T, et al. The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg. 2001;182:177-182.
23. Tanaka T, Yamanaka N, Oriyama T, et al. Factors regulating tumor pressure in hepatocellular carcinoma and implications for tumor spread. Hepatology. 1997;26:283-287.
24. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer. 1994;74:2772-2780.
25. Thomas DH, Verghese A, Kynaston HG, et al. Analysis of the prognostic implications of different tumour margin types in renal cell carcinoma. Histopathology. 2003;43:374-380.
26. Tortoledo ME, Luna MA, Batsakis JG. Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol. 1984;110:172-176.
27. Toyosaka A, Okamoto E, Mitsunobu M, et al. Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel. Am J Gastroenterol. 1996;91: 1610-1615.
28. Tryggvason K, Höyhtyä M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat. 1993;24:209-218.
29. UICC. TNM Classification of Malignant Tumours. NY: Wiley-Liss; 1997:296-302.
30. Wu CC, Cheng SB, Ho WM, et al. Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 2005;92: 348-355.